Current Portfolio
VarmX
Dutch biotech company developing an innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants.
Key Facts
- Sector
Life Sciences
- Country
Netherlands
- Fund
LSP 6
- Entry
2020
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.